Finance

Lists
002412:SHE
Hunan Hansen Pharmaceutical Co., Ltd
CNÂ¥8.13
+1.12%
(+0.090) 1D
Oct 21, 3:04:51 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002412...
Open
CNÂ¥8.10
High
CNÂ¥8.28
Low
CNÂ¥8.10
Mkt. cap
4.05B
Avg. vol.
52.46M
Volume
17.74M
Dividend
3.69%
Quarterly dividend
CNÂ¥0.08
Ex-dividend date
Jun 16, 2026
P/E ratio
20.69
52-wk high
CNÂ¥14.23
52-wk low
CNÂ¥5.32
EPS
CNÂ¥0.39
Shares outstanding
503.20M
No. of employees
2K
Open
CNÂ¥8.10
High
CNÂ¥8.28
Low
CNÂ¥8.10
Mkt. cap
4.05B
Avg. vol.
52.46M
Volume
17.74M
Dividend
3.69%
Quarterly dividend
CNÂ¥0.08
Ex-dividend date
Jun 16, 2026
P/E ratio
20.69
52-wk high
CNÂ¥14.23
52-wk low
CNÂ¥5.32
EPS
CNÂ¥0.39
Shares outstanding
503.20M
No. of employees
2K
News stories
From web sources and news partners
About Hunan Hansen Pharmaceutical Co., Ltd
CEO-
Employees2.11K
FoundedJan 21, 1998
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
231.94M
297.96M
263.23M
212.94M
Cost of goods sold
49.32M
71.30M
54.49M
50.45M
Cost of revenue
49.32M
71.30M
54.49M
50.45M
Research and development expenses
8.73M
11.80M
8.96M
7.79M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
137.61M
139.68M
133.38M
110.67M
Operating expense
153.95M
154.58M
150.38M
119.01M
Total operating expenses
203.27M
225.88M
204.88M
169.45M
Operating income
28.67M
72.08M
58.35M
43.49M
Other non operating income
2.63M
-7.17M
-34.69K
-4.54M
EBT including unusual items
16.13M
125.49M
48.40M
74.40M
EBT excluding unusual items
31.27M
71.16M
58.32M
61.36M
Income tax expense
2.14M
9.90M
9.99M
6.22M
Effective tax rate
13.28%
7.89%
20.65%
8.35%
Other operating expenses
4.90M
5.82M
3.53M
5.06M
Net income
13.99M
115.60M
38.41M
68.19M
Net profit margin
6.03%
38.80%
14.59%
32.02%
Earnings per share
-
-
-
-
Interest and investment income
307.92K
6.57M
298.18K
22.62M
Interest expense
-342.82K
-321.47K
-297.33K
-215.50K
Net interest expenses
-34.90K
6.25M
849.00
22.41M
Depreciation and amortization charges
-
-
-
-
EBITDA
38.77M
82.14M
68.41M
53.39M
Gain or loss from assets sale
-448.85K
15.06K
-
47.45K
AI content may include mistakes. Learn more
Google apps